Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
87 /100
CRITICAL RISK
Score updated Oct 13, 2026

INO — Inovio Pharmaceuticals, Inc. Dilution Risk Tracker

Track INO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track INO — Get alerts when the score changes →

As of October 13, 2026, Inovio Pharmaceuticals, Inc. (INO) has a DilutionWatch DilutionScore of 87/100, rated CRITICAL dilution risk. Inovio Pharmaceuticals, Inc. has a market capitalization of $114.25M, 103.40M shares outstanding, 101 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $17.50M, 49.29M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
85
📊 Float Risk
45
⚠️ Warrant Exposure
90
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 54%
📜 Warrant Exercise model 60%
• Massive warrant overhang: 48% of shares outstanding
• Warrant risk score very high (90/100)
💰 Capital Raise model 53%
• Low cash runway: 4 months remaining
• Active ATM program with $18M remaining capacity
🔄 Reverse Split model est. 45%
• 50-day avg $1.29 approaching $1 threshold
• Only 4 months cash — financial pressure
🔔 Track INO — Get forecast alerts →

Market Data

Market Cap$114.25M
Shares Outstanding103.40M
Float81.93M
Cash$36.67M
Debt$62.76M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore87/100DilutionWatch score record
Shares Outstanding103.40MVerified float table or market cache
Public Float81.93MVerified float table or market cache
Market Cap$114.25MMarket data cache
Cash Runway3.9 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM Capacity$17.50MSEC-derived dilution fields
Outstanding Warrants49.29MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 8-K 1, SC 13G 2, SC 13G/A 2, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 3.1% shares (2026Q1 vs prior)
101 institutional holders · 39.41M shares
#1 FMR LLC 9.34M shares
#2 JANUS HENDERSON GROUP PLC 6.62M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 5.80M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest20.82M
Days to Cover7.6
% of Float25.4%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-12
xbrl XBRL CONVERTIBLE 2024-03-06
SC 13G/A BENEFICIAL OWNERSHIP 2026-08-12
SC 13G BENEFICIAL OWNERSHIP 2026-08-07
SC 13G/A BENEFICIAL OWNERSHIP 2026-08-06
Full SEC filing analysis available with free account →

Recent News

Factual INO Dilution Snapshot

Inovio Pharmaceuticals, Inc. (INO) has a DilutionScore of 87/100, rated Critical dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

INO's DilutionScore is currently 87/100 (Critical risk), with 4 score changes tracked over 89 days. The score improved from 77/100 (Critical risk).

Period Score Risk Level Duration
Sep 28 – Oct 13, 202687/100CRITICAL16 days
Sep 13 – Sep 27, 202677/100CRITICAL15 days
Aug 22 – Sep 12, 202676/100CRITICAL22 days
Aug 14 – Aug 21, 202679/100CRITICAL7 days
Jul 16 – Aug 13, 202662/100HIGH29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

INO shares outstanding have increased 19.8% from 68.70M (Mar 2026) to 82.27M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 15, 202682.27M81.93M▲ 19.08%
Apr 07, 202681.59M68.81M▲ 0.08%
Mar 14, 202668.70M68.75M▲ 28.97%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track INO Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment INO files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking INO — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for INO
INO FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.